Business Impacts of COVID-19 on U.S. Prostate Cancer Treatment Devices Market | Strategies of Major Industry Competitors

1. U.S. Prostate Cancer Treatment Devices Market Set to Generate Over $150.0 Million Revenue By 2030 © P&S Intelligence. All rights reserved Page 1

2. The U.S. prostate cancer treatment devices market is predicted to advance at a CAGR of 5.6% from 2020 to 2030 and generate a revenue of $157.1 million by 2030. The growing usage of technologically advanced and innovative prostate cancer treatment devices in various healthcare settings for providing better medical treatment to patients is a major factor fueling the growth of the market. The other key factor propelling the expansion of the market is the rising requirement for automated prostate cancer treatment devices, on account of the rapid advancements in treatment procedures in the country. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/us- prostate-cancer-treatment-device-market-revenue/report-sample The progress of the U.S. prostate cancer treatment devices market has been considerably slowed down by the COVID-19 pandemic. Moreover, the rapid spread of the virus and the ballooning number of infected persons have augmented the burden on healthcare settings and services. Many states in the country have imposed either partial or complete lockdowns for reducing the spread of the virus and this has resulted in the shutting down of manufacturing plants. Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry- url=us-prostate-cancer-treatment-device-market-revenue Depending on type, the U.S. prostate cancer treatment devices market is divided into surgery, radiation, high-intensity focused ultrasound (HIFU), cryotherapy, and others. Out of these, the highest revenue share was held by the radiation category in the past years. This was because of the abundant availability of these systems, the large-scale usage of various radiation therapy devices, and the existence of numerous radiation therapy devices producing companies in the country. Under the end user segment of the U.S. prostate cancer treatment devices market, the main categories are specialty centers and hospitals. Of these, the hospitals category registered higher share in the market in the years gone by and this trend is likely to continue in the forthcoming years. As per the American Hospital Association (AHA), there were as many as 6,146 hospitals in the country in 2018. The growth of the hospitals category in the market is mainly because of the existence of several hospitals in several states and the burgeoning sales of the treatment devices by the major manufacturing firms directly to the hospitals. © P&S Intelligence. All rights reserved Page 2

3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved © P&S Intelligence. All rights reserved Page 3